AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10771448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone 40-120 mg day(-1)
Number of subjects: 0
Study 10771448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone (various doses)
Number of subjects: 0
Study 10771448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8834415 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg haloperidol
Number of subjects: 12
Study 8834415 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg haloperidol with nefazodone
Number of subjects: 12
Study 8834415 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 12
Study 8834415 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone and haloperidol
Number of subjects: 12
Study 1731545 — intervention group
Group type: COMPARATOR
Intervention: 1 mL of 0.9% saline
Number of subjects: 368
Study 1731545 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL of 0.5% (5 mg) lidocaine
Number of subjects: 368
Study 1731545 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL of 1% (10 mg) lidocaine
Number of subjects: 368
Study 1731545 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL of 2% (20 mg) lidocaine
Number of subjects: 368
Study 6439286 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg twice daily for four weeks
Number of subjects: 10
Study 6439286 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 250 mg twice daily for four weeks
Number of subjects: 10
Study 6439286 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg twice daily for four weeks
Number of subjects: 10
Study 6439286 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg a day (diuretic treatment)
Number of subjects: 10
Study 31714453 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 7
Study 31714453 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 7
Study 31714453 — intervention group
Group type: COMPARATOR
Intervention: Continuous Training (CT)
Number of subjects: 7
Study 31714453 — intervention group
Group type: EXPERIMENTAL
Intervention: All training protocols (HIT, SIT, CT)
Number of subjects: 7
Study 30625023 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial Counseling (FC) intervention including education, financial assistance screening, and an estimation tool for out-of-pocket costs of chemotherapy.
Number of subjects: 95
Study 30625023 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial Counseling (FC) intervention
Number of subjects: 95
Study 30625023 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 95
Study 29016721 — intervention group
Group type: EXPERIMENTAL
Intervention: Unit information present, calorie information present
Number of subjects: 0
Study 29016721 — intervention group
Group type: EXPERIMENTAL
Intervention: Unit information present, calorie information absent
Number of subjects: 0
Study 29016721 — intervention group
Group type: EXPERIMENTAL
Intervention: Unit information absent, calorie information present
Number of subjects: 0
Study 29016721 — intervention group
Group type: EXPERIMENTAL
Intervention: Unit information absent, calorie information absent
Number of subjects: 0
Study 26566960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided catheter placement
Number of subjects: 210
Study 26566960 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulation-guided catheter placement
Number of subjects: 210
Study 25789827 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate care
Number of subjects: 286
Study 25789827 — intervention group
Group type: COMPARATOR
Intervention: Standard ward care
Number of subjects: 286
Study 23017609 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care with music therapy
Number of subjects: 200
Study 23017609 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 200
Study 20959312 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90
Study 18986067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bistable display with shading cues (Rubin's vase illusion)
Number of subjects: 5
Study 18986067 — intervention group
Group type: COMPARATOR
Intervention: Control bistable display (disc/aperture test)
Number of subjects: 5
Study 18986067 — intervention group
Group type: EXPERIMENTAL
Intervention: Vase/face test with shading cues
Number of subjects: 5
Study 16646127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training based on PASAT and two new versions of this task
Number of subjects: 15
Study 14662581 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 25
Study 14662581 — intervention group
Group type: COMPARATOR
Intervention: Apple juice
Number of subjects: 25
Study 10962164 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal prenatal attachment measured by the Prenatal Attachment Inventory (PAI)
Number of subjects: 100
Study 10962164 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal prenatal attachment measured by PAI-factors such as interaction and affection
Number of subjects: 100
Study 10962164 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal prenatal attachment measured by PAI-factors such as differentiation of self with the unborn baby
Number of subjects: 100
Study 10962164 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal responsive behaviour
Number of subjects: 100
Study 8995042 — intervention group
Group type: EXPERIMENTAL
Intervention: Spouse-aided treatment
Number of subjects: 23
Study 8995042 — intervention group
Group type: COMPARATOR
Intervention: Individual behavioral-cognitive therapy
Number of subjects: 23
Study 1317237 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing care from the clinic
Number of subjects: 40
Study 1317237 — intervention group
Group type: COMPARATOR
Intervention: General practitioners' management with specialist support
Number of subjects: 40
Study 3981394 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjectives listed with their dictionary definitions
Number of subjects: 0
Study 3981394 — intervention group
Group type: COMPARATOR
Intervention: Adjectives listed without definitions
Number of subjects: 0
Study 31005945 — intervention group
Group type: EXPERIMENTAL
Intervention: Getting Older Adults Outdoors (GO-OUT) intervention: 1-day interactive workshop and 10-week group outdoor walking programme (two 1-hour sessions/week)
Number of subjects: 240
Study 31005945 — intervention group
Group type: COMPARATOR
Intervention: Workshop and weekly reminders (WR)
Number of subjects: 240
Study 31005945 — intervention group
Group type: EXPERIMENTAL
Intervention: GO-OUT intervention
Number of subjects: 240
Study 31005945 — intervention group
Group type: COMPARATOR
Intervention: WR intervention
Number of subjects: 240
Study 29239682 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent seasonal influenza vaccine (15 μg of hemagglutinin per strain)
Number of subjects: 60
Study 29239682 — intervention group
Group type: COMPARATOR
Intervention: Placebo (phosphate-buffered saline)
Number of subjects: 60
Study 26968609 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrax biofeedback games (20 minutes, 3 times a week for 6 weeks)
Number of subjects: 27
Study 26968609 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation training
Number of subjects: 27
Study 25197826 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention (6 counseling sessions approximately monthly)
Number of subjects: 818
Study 25197826 — intervention group
Group type: COMPARATOR
Intervention: Equal-attention control group (6 nutrition sessions)
Number of subjects: 818
Study 25197826 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention
Number of subjects: 818
Study 22793966 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.5mg.kg(‐1)) in 5 mL fruit juice
Number of subjects: 100
Study 22793966 — intervention group
Group type: COMPARATOR
Intervention: Fruit juice (control group)
Number of subjects: 100
Study 20460227 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (Low dose: 85 mg/d)
Number of subjects: 257
Study 20460227 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (Medium dose: 230 mg/d)
Number of subjects: 257
Study 20460227 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (High dose: 500 mg/d)
Number of subjects: 257
Study 18515187 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of intervention (Group format)
Number of subjects: 1075
Study 18515187 — intervention group
Group type: COMPARATOR
Intervention: Assigned Group format
Number of subjects: 1075
Study 15893155 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg HYD/500 mg ACET
Number of subjects: 18
Study 15893155 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg HYD/500 mg ACET
Number of subjects: 18
Study 15893155 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg HYD/1000 mg ACET
Number of subjects: 18
Study 15893155 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg morphine sulfate (MOR)
Number of subjects: 18
Study 15893155 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg ACET
Number of subjects: 18
Study 15893155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 12739903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation treatment
Number of subjects: 38
Study 12739903 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 38
Study 10526246 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) for 6 months
Number of subjects: 22
Study 10526246 — intervention group
Group type: COMPARATOR
Intervention: placebo for 6 months
Number of subjects: 22
Study 10526246 — intervention group
Group type: EXPERIMENTAL
Intervention: GHD patients
Number of subjects: 22
Study 7978473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (30 micrograms)
Number of subjects: 12
Study 7978473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 micrograms)
Number of subjects: 12
Study 7978473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural alfentanil (300 micrograms)
Number of subjects: 12
Study 7978473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural alfentanil (1,000 micrograms)
Number of subjects: 12
Study 7978473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (3 micrograms)
Number of subjects: 12
Study 7978473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (10 micrograms)
Number of subjects: 12
Study 7978473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2563735 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycemic clamp protocol (plasma glucose approximately 5.6 mmol/L) for 4 h
Number of subjects: 20
Study 2563735 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemic clamp protocol (plasma glucose about 11 mmol/L) for 4 h
Number of subjects: 20
Study 1102147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-nasal grass pollen extract
Number of subjects: 42
Study 1102147 — intervention group
Group type: COMPARATOR
Intervention: Carbol saline (placebo)
Number of subjects: 42
Study 1102147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal hyposensitization
Number of subjects: 42
Study 31330091 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia patients
Number of subjects: 81192
Study 31330091 — intervention group
Group type: COMPARATOR
Intervention: Controls (age- and gender-matched, no dementia diagnosis)
Number of subjects: 81192
Study 31330091 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 81192
Study 31697873 — intervention group
Group type: EXPERIMENTAL
Intervention: Elexacaftor-tezacaftor-ivacaftor
Number of subjects: 403
Study 31697873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 28188418 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic nimodipine treatment
Number of subjects: 112
Study 25300574 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ginger
Number of subjects: 593
Study 25300574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593
Study 24320723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking with Kids (CWK) program including a 1-hour introductory lesson, three 2-hour cooking classes, and three 1-hour fruit and vegetable tasting sessions for one semester.
Number of subjects: 257
Study 24320723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking with Kids (CWK) program
Number of subjects: 257
Study 21302483 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola
Number of subjects: 42
Study 21302483 — intervention group
Group type: COMPARATOR
Intervention: Control (no Rhodiola)
Number of subjects: 42
Study 18097218 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir monotherapy
Number of subjects: 205
Study 18097218 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (lopinavir-ritonavir and two nucleosides)
Number of subjects: 205
Study 16472960 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-picture versions of instructions for inhaler chamber
Number of subjects: 99
Study 16472960 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-picture versions of instructions for peak flow meter
Number of subjects: 99
Study 16472960 — intervention group
Group type: COMPARATOR
Intervention: Original text-only versions of instructions for inhaler chamber
Number of subjects: 99
Study 16472960 — intervention group
Group type: COMPARATOR
Intervention: Original text-only versions of instructions for peak flow meter
Number of subjects: 99
Study 12500080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep quality and quantity (measured by sleep efficiency and sleep latency)
Number of subjects: 60
Study 12500080 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter sleep duration
Number of subjects: 60
Study 12500080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep efficiency
Number of subjects: 60
Study 12500080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep latency
Number of subjects: 60
Study 10802845 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Care Manual of the Perinatal Education Program
Number of subjects: 73
Study 10802845 — intervention group
Group type: COMPARATOR
Intervention: Control towns (no intervention)
Number of subjects: 73
Study 9368551 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (t-PA)
Number of subjects: 0
Study 9368551 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 0
Study 1329482 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat plus high-fiber diet
Number of subjects: 3
Study 1329482 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 3
Study 1329482 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 3
Study 3932050 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 100 micrograms q.i.d.
Number of subjects: 299
Study 3932050 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 25 micrograms q.i.d.
Number of subjects: 299
Study 3932050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 3932050 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 299
Study 3932050 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 100 micrograms
Number of subjects: 299
Study 3932050 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 25 micrograms
Number of subjects: 299
Study 30735341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy with low weight transvaginal polypropylene mesh
Number of subjects: 1
Study 30735341 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic mesh for POP surgery correction
Number of subjects: 1
Study 29397524 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial synchronous biventricular pacing (CRT-P)
Number of subjects: 0
Study 29397524 — intervention group
Group type: COMPARATOR
Intervention: AV node ablation
Number of subjects: 0
Study 26873942 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous monitoring using an implantable loop recorder plus standard monitoring
Number of subjects: 0
Study 26873942 — intervention group
Group type: COMPARATOR
Intervention: Standard heart rhythm monitoring alone
Number of subjects: 0
Study 25284162 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS supported employment service
Number of subjects: 208
Study 25284162 — intervention group
Group type: COMPARATOR
Intervention: Control condition (referral to other disability employment services)
Number of subjects: 208
Study 22827512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling jacket (Cryovest; V)
Number of subjects: 9
Study 22827512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool water immersion (20 °C; CWI)
Number of subjects: 9
Study 22827512 — intervention group
Group type: COMPARATOR
Intervention: Passive control (PAS)
Number of subjects: 9
Study 19802729 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with distal protection devices (DPDs)
Number of subjects: 96
Study 17644629 — intervention group
Group type: EXPERIMENTAL
Intervention: HA enriched commercial embryo transfer medium
Number of subjects: 101
Study 17644629 — intervention group
Group type: COMPARATOR
Intervention: Routine embryo transfer medium without HA
Number of subjects: 101
Study 15619390 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (12.5 to 25.0 mg/day)
Number of subjects: 4732
Study 15619390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4732
Study 15619390 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subjects who developed diabetes during the trial)
Number of subjects: 4732
Study 15619390 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic therapy (subjects who developed diabetes during treatment)
Number of subjects: 4732
Study 15619390 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (in subjects with diabetes)
Number of subjects: 4732
Study 11871954 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 degrees head-up tilt
Number of subjects: 40
Study 11871954 — intervention group
Group type: COMPARATOR
Intervention: Horizontal position (Control)
Number of subjects: 40
Study 10190266 — intervention group
Group type: EXPERIMENTAL
Intervention: 677C-->T mutation analysis in patients with neural tube defects and their parents
Number of subjects: 91
Study 10190266 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 91
Study 7749698 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection of adrenaline (1:10,000) followed by heater probe thermocoagulation
Number of subjects: 153
Study 7749698 — intervention group
Group type: COMPARATOR
Intervention: No endoscopic treatment
Number of subjects: 153
Study 1921531 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol for characterizing drug-related problems
Number of subjects: 706
Study 7108059 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 32
Study 7108059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 30003839 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief guided cognitive behavioral treatment (CBT) for perfectionism delivered via a self-help booklet
Number of subjects: 60
Study 30003839 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study 29580940 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy (measured with the Self-Efficacy of Managing Chronic Disease questionnaire - SEMCD)
Number of subjects: 38
Study 29580940 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional capacity (measured with the Prosthesis Evaluation Questionnaire–Mobility Scale - PEQ-MS)
Number of subjects: 38
Study 29580940 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability (measured with WHODAS 2.0)
Number of subjects: 38
Study 29580940 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlling for SEMCD
Number of subjects: 38
Study 29580940 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation analysis
Number of subjects: 38
Study 27477473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervicothoracic manual therapy plus exercise therapy
Number of subjects: 140
Study 27477473 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 140
Study 23961726 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP)
Number of subjects: 1267
Study 23961726 — intervention group
Group type: COMPARATOR
Intervention: Methadone (MET)
Number of subjects: 1267
Study 23961726 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine/naloxone (BUP) vs Methadone (MET)
Number of subjects: 1267
Study 22340428 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-38431055 (100 mg single-dose)
Number of subjects: 57
Study 22340428 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-38431055 (500 mg single-dose)
Number of subjects: 57
Study 22340428 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-38431055 (500 mg once daily for 14 days)
Number of subjects: 57
Study 22340428 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin (100 mg single-dose)
Number of subjects: 57
Study 22340428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 20090397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) consisting of ten consecutive weekly sessions
Number of subjects: 45
Study 20090397 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study 17678902 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desogestrel (n = 30) for 10 days combined with a tablet of raloxifene (60 mg) per vaginam (group A)
Number of subjects: 90
Study 17678902 — intervention group
Group type: COMPARATOR
Intervention: Oral desogestrel at 60 mg/day (n = 30; group B)
Number of subjects: 90
Study 17678902 — intervention group
Group type: COMPARATOR
Intervention: Oral danazol at 200 mg, three times a day (n = 30; group C)
Number of subjects: 90
Study 17678902 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 90
Study 16236844 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nebulized racemic glycopyrrolate (0.5, 1.0, and 2.0 mg)
Number of subjects: 10
Study 16236844 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (0.5 mg)
Number of subjects: 10